Related Experiment Video
Updated: Jul 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate
J P Dwyer1, K M Yates, E L Sumner
1Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract:
There is no known clinical association between chronic myelogenous leukemia (CML) and membranoproliferative glomerulonephritis (MPGN). We present a patient who was followed in the renal clinic for proteinuria of unknown etiology (3.2 g/24 h) and normal renal function who was diagnosed with CML as well as MPGN and acute renal failure at the same time. The patient's renal function and proteinuria improved when his CML was treated with imatinib mesylate, suggesting that CML either caused or exacerbated existing MGPN. To the best of our knowledge, this is the first reported case of MPGN associated with CML that improved with imatinib mesylate therapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Chronic Kidney Disease III: Interprofessional Care
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nephrotic Syndrome I : Introduction